Skip to main content
MindBio Therapeutics Corp. logo

MindBio Therapeutics Corp. — Investor Relations & Filings

Ticker · MBIO ISIN · CA60256C2076 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 113 across all filing types
Latest filing 2025-03-17 Capital/Financing Update
Country CA Canada
Listing CSE MBIO

About MindBio Therapeutics Corp.

https://mindbiotherapeutics.com/

MindBio Therapeutics Corp. develops and commercializes AI-powered health prediction technologies utilizing proprietary acoustic biomarkers extracted from the human voice. The company's core offering is a comprehensive enterprise platform designed for real-time intoxication and impairment detection, primarily focusing on sobriety verification in safety-critical environments. This platform employs machine learning algorithms to analyze over 140 acoustic parameters, such as jitter, shimmer, and spectral entropy, achieving greater than 88% prediction accuracy in under three seconds. Target markets include zero-tolerance industries like aviation, mining, and construction, requiring scalable, non-invasive fitness-for-duty verification. The technology transforms speech into actionable health intelligence for workforce monitoring and advanced telehealth applications.

Recent filings

Filing Released Lang Actions
Other material contracts - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a binding loan terms sheet detailing financing arrangements between MindBio and a lender, including loan amount, interest, repayment schedule and share bonus provisions. It is a private financing contract rather than an earnings release, management report or regulatory notice. Therefore it best fits the “Capital/Financing Update” category.
2025-03-17 English
Other material contracts - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a binding loan term sheet detailing the terms of a financing arrangement (loan amount, interest, repayment, warranties, security, etc.). It is not a regulatory announcement or an annual/interim report, nor is it an earnings release or call transcript. It clearly outlines capital/funding terms between a lender and the company, which fits the Capital/Financing Update category (CAP).
2025-03-17 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release announcing the successful outcome of a mandatory independent safety audit on clinical trials. It is not a financial report (10-K, IR), dividend notice, M&A announcement, or any specialized regulatory form. It is a general company announcement that does not fit other specific categories, so it defaults to the general regulatory announcement/fallback category RNS.
2025-01-28 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 45-106F1) used to report an exempt distribution of securities under National Instrument 45-106. It is not an earnings release, annual report, prospectus, or presentation – it is a formal regulatory filing notifying authorities of a share distribution event. There is no specialized category for NI 45-106 distributions, so it falls under the fallback “Regulatory Filings” category (RNS).
2025-01-21 English
Material change report - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a Canadian NI 51-102F3 Material Change Report announcing a non-brokered private placement (sale of new shares) and the conversion of debt into shares. It details new share issues and capital structure changes rather than a general financing overview or repurchase. This matches the ‘Share Issue/Capital Change’ category (SHA).
2025-01-21 English
News release - English.pdf
M&A Activity Classification · 1% confidence The document is a corporate press release announcing that MindBio Therapeutics has entered into a letter of intent to acquire Life AI Corp Pty Ltd, detailing the structure of the proposed acquisition (issuance of shares, conditions precedent, related party aspects, etc.). This clearly falls under M&A Activity announcements. Therefore, it should be classified as Code TAR (M&A Activity).
2025-01-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.